You have 9 free searches left this month | for more free features.

Primary HIV Infection

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

s From HIV Infection, KSHV Infection, Viral-Related

Recruiting
  • HIV
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    HIV Primary Infection Trial in Barcelona (50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide)

    Recruiting
    • HIV Primary Infection
    • 50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide
    • Barcelona, Spain
      Hospital Clinic
    Jul 16, 2021

    Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction

    Not yet recruiting
    • Hiv
    • +5 more
    • differences in CD4 reconstruction
    • (no location specified)
    Sep 17, 2023

    HIV Infection Primary Trial (an adaptation of the iENGAGE)

    Not yet recruiting
    • HIV Infection Primary
    • an adaptation of the iENGAGE
    • (no location specified)
    Jul 7, 2023

    HIV Trial in United States (Zidovudine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +8 more
    Oct 27, 2021

    Acceptability of Health Care, HIV Primary Infection Trial in Ann Arbor (Kicking it with the Gurlz)

    Active, not recruiting
    • Acceptability of Health Care
    • HIV Primary Infection
    • Kicking it with the Gurlz
    • Ann Arbor, Michigan
      University of Michigan
    Jan 23, 2023

    HIV Infection Primary, Hepatitis, Viral, Human, Sexually Transmitted Infections, Excluding HIV and Hepatitis Trial in Seville

    Enrolling by invitation
    • HIV Infection Primary
    • +2 more
    • Tenofovir Disoproxil Fumarate 300 MG Oral Tablet
    • Seville, Andalusia, Spain
      Virgen del Rocío University Hospital
    Aug 5, 2022

    HIV Infection Primary Trial in Miami (INSTACARE)

    Recruiting
    • HIV Infection Primary
    • INSTACARE
    • Miami, Florida
      University of Miami
    Aug 16, 2022

    HIV-1-infection, Sexually Transmitted Diseases Trial in Somkele (Community-based differentiated HIV prevention incl.PrEP with

    Recruiting
    • HIV-1-infection
    • Sexually Transmitted Diseases
    • Community-based differentiated HIV prevention incl.PrEP with SRH
    • Primary Health Clinic based HIV prevention and care
    • Somkele, KwaZulu-Natal, South Africa
      Africa Health Research Institute
    Aug 4, 2022

    HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,

    Completed
    • HIV-1 Infection
    • All The Regions Of The Country (40 Centers), France
      (unnamed)
    Jan 3, 2022

    HIV Infection Primary Trial in Badalona (Dasatinib 70 mg, Placebo)

    Not yet recruiting
    • HIV Infection Primary
    • Dasatinib 70 mg
    • Placebo
    • Badalona, Barcelona, Spain
      Hospital Universitari Germans Trias i Pujol
    Mar 9, 2023

    Primary Resistance in HIV Patients in Colombia

    Recruiting
    • HIV Infection
    • HIV-1 plasma RNA Genotyping secuencing by Sanger technique
    • HIV-1 plasma RNA Genotyping secuencing by Ultra-deep sequencing technique
    • Cali, Valle, Colombia
      REVIVA, Red de VIH del Valle del Cauca
    Jan 17, 2022

    HIV/AIDS and Infections Trial in London (Investigational Medicinal Product)

    Recruiting
    • HIV/AIDS and Infections
    • Investigational Medicinal Product
    • London, United Kingdom
      Imperial College NHS Healthcare Trust
    Jul 5, 2021

    The Visceral Adiposity Measurement and Observation Study

    Recruiting
    • HIV
    • +18 more
    • Diagnostic Test
    • HIV Anti-retroviral Background Therapy
    • Los Angeles, California
    • +5 more
    Sep 21, 2022

    GALIG Gene Products in HIV-1 Infected Under Antiretroviral

    Recruiting
    • Autophagy
    • +3 more
    • expression of a panel
    • Orléans, France
      CHR d'Orleans
    Nov 17, 2021

    Diphtheria, Tetanus, Pertussis Trial in Soweto (Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine)

    Completed
    • Diphtheria
    • +5 more
    • Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
    • Soweto, South Africa
      (unnamed)
    Mar 24, 2022

    HIV, Risk Reduction, Risk Behavior Trial in Rio de Janeiro, Rio De Janeiro (HIV testing)

    Completed
    • HIV Infections
    • +6 more
    • HIV testing
    • Rio de Janeiro, RJ, Brazil
    • +1 more
    Jan 5, 2023

    HIV, HIV Primary Infection Trial in San Francisco (CHIP, Control)

    Recruiting
    • HIV Infections
    • HIV Primary Infection
    • CHIP
    • Control
    • San Francisco, California
      University of California, San Francisco
    Feb 28, 2022

    Primary Infection Cohort

    Recruiting
    • HIV-1-infection
    • blood sampling
    • Le Kremlin Bicêtre, France
      Laurence Meyer
    May 20, 2021

    HIV/AIDS and Infections Trial in France (Recombinant human mAb (bNAbs), Placebo)

    Not yet recruiting
    • HIV/AIDS and Infections
    • Recombinant human monoclonal antibody (bNAbs)
    • Placebo
    • Bobigny, France
    • +16 more
    Mar 18, 2022

    Sexually Transmitted Infection, Chlamydia, Gonorrhea Trial (Point-of-care STI testing)

    Not yet recruiting
    • Sexually Transmitted Infection
    • +8 more
    • Point-of-care STI testing
    • (no location specified)
    Sep 12, 2022

    Self Efficacy, HIV Prevention, STI Prevention Trial in Philadelphia (Treat Act Know Engage (T.A.K.E.) Steps, Standard or Care)

    Recruiting
    • Self Efficacy
    • +2 more
    • Treat Act Know Engage (T.A.K.E.) Steps
    • Standard or Care
    • Philadelphia, Pennsylvania
    • +1 more
    Mar 8, 2022

    HIV Indicator Diseases in Hospital and Primary Care

    Recruiting
    • HIV Infections
    • +17 more
    • Peer to peer feedback
    • HIV rapid test
    • Rotterdam, South-Holland, Netherlands
      Carlijn CCE Jordans
    Jan 26, 2022

    HIV Trial (Abacavir sulfate, Didanosine, Efavirenz)

    Completed
    • HIV Infections
    • Abacavir sulfate
    • +6 more
    • (no location specified)
    Oct 29, 2021

    Tuberculosis Trial in Saint Petersburg (GamTBvac, Placebo)

    Recruiting
    • Tuberculosis
    • GamTBvac
    • Placebo
    • Saint Petersburg, Russian Federation
      City hospital #40
    Jan 20, 2022